ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.60
-0.34%
US Tech 100
17,650.00
0.05%
S&P 500
5,222.68
0.16%
US Dollar vs CAD
1.36785
0.00%
Bitcoin
60,925.96
0.22%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Avalon Pharmaceuticals (MM) (AVRX)

  7. Avalon Pharmaceuticals (MM) (AVRX) News

AVRX

Avalon (AVRX)

Avalon Pharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AVRX
DateTimeSourceHeadlineSymbolCompany
05/13/20092:39PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
05/06/20093:48PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
05/06/20093:46PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
04/28/20094:05PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
04/28/20093:49PMBusiness WireAvalon Pharmaceuticals Announces Special Meeting DateNASDAQ:AVRXAvalon Pharmaceuticals (MM)
04/07/20092:00PMBusiness WireAvalon Pharmaceuticals Receives Audit Opinion Containing Going Concern StatementNASDAQ:AVRXAvalon Pharmaceuticals (MM)
04/02/20099:24AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
04/02/20099:22AMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
03/31/20093:02PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
03/17/20094:07PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
03/17/20094:05PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
03/17/20092:00PMBusiness WireAvalon Pharmaceuticals Receives Staff Determination Regarding Nasdaq DelistingNASDAQ:AVRXAvalon Pharmaceuticals (MM)
03/10/20093:07PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
02/17/20094:22PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
02/17/200910:35AMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
02/13/20092:10PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
02/13/20091:29PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
02/11/20093:11PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
02/10/20094:04PMEdgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
01/30/20093:29PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
01/21/20093:19PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
01/14/200910:56AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
01/14/200910:54AMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
12/22/20083:58PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
12/22/20083:56PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
12/22/20083:23PMBusiness WireAvalon Pharmaceuticals Receives Extension of Time to Comply with NASDAQ Deficiency NoticeNASDAQ:AVRXAvalon Pharmaceuticals (MM)
11/25/20083:06PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
11/25/20081:18PMBusiness WireAvalon Pharmaceuticals Receives NASDAQ Deficiency NoticeNASDAQ:AVRXAvalon Pharmaceuticals (MM)
11/13/200811:04AMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
11/10/200812:39PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:AVRX

Your Recent History

USOTC
TXTM
ProText Mobility (PK)
NASDAQ
RVNC
Revance Therapeutics
NASDAQ
RNAZ
TransCode Therapeutics
USOTC
VDRM
ViaDerma (PK)
USOTC
IBGR
Nexus Energy Services (PK)
USOTC
RDAR
Raadr (PK)
USOTC
NSAV
Net Savings Link (PK)
USOTC
PHIL
PHI (PK)
USOTC
SONG
Music Licensing (PK)
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
RONN
Ronn Motor (PK)
USOTC
TDRK
TideRock Companies (PK)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
AXXA
Exxe (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved